Telehealth & Digital Health

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

New at-home tests for IBS and SIBO are gaining validation, promising faster diagnoses and revealing surprising links between gut health and systemic diseases.

TRexBio has dosed the first patient in a new trial for its novel drug, TRB-061, which aims to rebalance the immune system to treat atopic dermatitis.

Anika Therapeutics posts strong Q1 results with a 13% revenue jump, but analyst caution lingers over pipeline risks and long-term sustainability.

A new partnership brings mask-free sleep apnea therapy to veterans, aligning with updated DoD/VA guidelines that prioritize patient preference and comfort.

A new at-home testing system aims to unite dentists and physicians, streamlining obstructive sleep apnea treatment for millions of undiagnosed patients.

A landmark study shows a novel device can safely treat severe artery blockages below the ankle, offering new hope for patients at risk of amputation.

A new cell-free therapy, Ultrasome™, shows a 93% response rate in a pilot study, offering a scalable, regenerative solution for millions with knee pain.

A North Chelmsford community is the only one in town to receive a 'Best' rating from U.S. News, offering families a new level of verified quality.

A new grant from Zymo Research aims to solve a key data problem in gut science, potentially unlocking the next wave of breakthroughs in personalized medicine.

WACKER is set to reveal a cost-saving XRF testing method and a breakthrough gamma-sterilizable medical adhesive, poised to impact two key sectors.

Top expert Dr. Henrik Zetterberg joins Circular Genomics, signaling a pivotal shift toward novel circular RNA blood tests for neurodegenerative disease.

Gifthealth won a top digital health award, but its real victory is in redefining the prescription journey with faster delivery and better patient outcomes.

A revolutionary organ preservation system is showing 100% graft survival in new studies, promising to expand the donor pool for children in need.

A new partnership brings a psychology-based diabetes reversal program to millions, offering a corporate-funded alternative to popular GLP-1 medications.

Dr. Dan Briggs is an EY Entrepreneur Of The Year finalist. His company, Auragens, offers stem cell therapy in Panama, raising questions about medical frontiers.

A new patient registry for a wireless, catheter-free device is set to power AI, promising a more accurate and dignified future for urological care.

TGA approves Minjuvi, a dual-targeted immunotherapy for relapsed follicular lymphoma, offering a breakthrough option beyond traditional chemotherapy.

A new financial deal shines a light on Modeyso, a breakthrough therapy for a rare pediatric brain cancer, linking Wall Street to life-saving innovation.

An essay contest for medical trainees aims to fix a critical gap in patient care, using frontline stories to reshape how doctors learn about nutrition.